BNB Plus Corp.

BNBX

US03815U6073

Investment Management & Fund Operators

Market Closed - OTC Markets 10:08:29 2026-07-14 EDT			5-day change	1st Jan Change
0.1630 ^USD	-.--%		+12.39%	-86.75%

09-05	Comstock MultiChain Fund, L P Engages with BNB Plus Corp	CI
09-03	BNB Plus Corp. Announces Board and Committee Changes, Effective September 3, 2026	CI

Top Premarket Decliners

Published on 09/30/2025 at 08:16 am EDT

MT Newswires

This article is reserved for our members.

Continue with Google Continue with Apple Continue with LinkedIn

or by email

Continue with an email.

Latest news about BNB Plus Corp.

09-05	Comstock MultiChain Fund, L P Engages with BNB Plus Corp	CI
09-03	BNB Plus Corp. Announces Board and Committee Changes, Effective September 3, 2026	CI
08-13	BNB Plus Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026	CI
07-29	BNB Plus Corp. Announces Board and Management Changes	CI
07-15	BNB Plus Corp.(OTCPK:BNBX) dropped from S&P TMI Index	CI
07-13	BNB Plus Receives Nasdaq Delisting Notice, Plans OTC Listing	MT
07-12	BNB Plus Corp.(OTCPK:BNBX) dropped from NASDAQ Composite Index	CI
05-25	BNB Plus Corp. announced that it expects to receive $5 million in funding from Silvermine Capital Advisors, LLC, Off The Chain Capital, LLC	CI
05-15	BNB Plus Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026	CI
04-20	BNB Plus Corp Announces Review of Strategic Alternatives to Maximize Shareholder Value	CI
03-25	Comstock MultiChain Fund, L P Engages with BNB Plus Corp	CI
02-12	BNB Plus Corp. Reports Earnings Results for the First Quarter Ended December 31, 2025	CI
02-05	BNB Plus Corp. Appoints James Haft as Independent Director and Nominating Committee Member, Effective February 2, 2026	CI
01-22	BNB Plus Corp. Announces Resignation of Director Elizabeth M. Schmalz Shaheen, Effective January 15, 2026	CI
01-05	BNB Plus Corp. Receives USD 1.2 Million Accelerated LineaDNA? Order	CI

BNB Plus Corp., formerly Applied DNA Sciences, Inc., is a digital asset treasury (DAT) company that has adopted BNB, the native cryptocurrency of the Binance blockchain ecosystem, as its primary reserve asset. Its segments include digital asset treasury, therapeutic deoxyribonucleic acid (DNA) production services, DNA tagging and security products and services. Its digital asset treasury segment is engaged in managing digital assets. Its therapeutic DNA production services segment is engaged in nucleic-acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP and LineaIVT. Its DNA tagging and security products and services segment is engaged in the manufacture and detection of DNA for industrial supply chains and security services. Its subsidiary LineaRx, Inc., is engaged in commercializing nucleic acid production solutions for the biopharmaceutical and diagnostics markets.

Employees

Sector

Investment Management & Fund Operators

More about the company